Expression and biosynthetic variation of the epidermal growth factor receptor in human hepatocellular carcinoma-derived cell lines.

• DOI: 10.1128/mcb.8.1.25
• Publication Date: 2015-09-30T19:44:54Z
• Authors: C R Carlin; D Simon; J Mattison; B B Knowles
• Keywords: 0301 basic medicine; 570; Carcinoma, Hepatocellular; Glycosylation; 610; Hepatoma: ge; Molecular-Weight; Gene-Amplification; 03 medical and health sciences; SUPPORT-U-S-GOVT-P-H-S; Isoelectric Point; Isoelectric-Point; Glycoproteins; Epidermal Growth Factor; Receptors-Epidermal-Growth-Factor-Urogastrone: ge; Liver Neoplasms; Glycoproteins: bi; Gene Amplification; DNA, Neoplasm; Liver-Neoplasms: ge; ErbB Receptors; Molecular Weight; Epidermal-Growth-Factor-Urogastrone: ph; Gene Expression Regulation; Karyotyping; Gene-Expression-Regulation; Protein Processing, Post-Translational; Protein-Processing-Post-Translational

Expression of the epidermal growth factor (EGF) was analyzed in six human hepatocellular carcinoma-derived and one human hepatoblastoma-derived cell line, each of which retained the differentiated phenotype and functions of the parenchymal hepatocyte. The level of receptor expression of each hepatoma cell line was similar to that of the normal human fibroblast, approximately 10(5) molecules per cell. However, NPLC/PRF/5, a subline of the PLC/PRF/5 cell line obtained following reestablishment of a xenograft tumor in vitro, was found to express 4 x 10(6) high-affinity EGF receptor molecules per cell. Proliferation of the NPLC/PRF/5 cell line was inhibited in the presence of nanomolar quantities of ligand. Receptor overexpression was found to result from EGF receptor gene amplification without apparent rearrangement of the EGF receptor coding sequences. Although cell-specific variability in posttranslational processing of EGF receptor N-linked oligosaccharides in the hepatoma cell lines was found, no difference between the receptors in PLC/PRF/5 and NPLC/PRF/5 was observed and no aberrant receptor-related species were detected. EGF receptor gene amplification in the NPLC/PRF/5 cell line is probably a reflection of genome instability and selection of variants with augmented growth potential in limiting concentrations of EGF in vivo. When viewed in this light, EGF receptor overexpression could represent a manifestation of tumor progression in the EGF-responsive hepatocyte.